Acerus reviews strategy in hopes to stay afloat
 

Today's Big News

Sep 21, 2022
 
 

Adamis’shares nosedive as sole clinical-stage asset flunks COVID-19 trial

Bay state biotechs Sesen and Carismablend together in bid to transform cancer treatment 

Cash-depleted Acerusundergoes strategic review to stay afloat

Puma pounces onfailed Takeda drug, snapping up cancer prospect for knockdown price

Rise of the machines: Novo Nordiskpledges $200M to create first quantum computer for life sciences

AbCellera doubles down on Vancouver, kicking off 2nd expansion phase to build integrated antibody R&D shop

 
 

Featured

 
 

Adamis’ shares nosedive as sole clinical-stage asset flunks COVID-19 trial

Another COVID-19 therapy bites the dust. This time it’s Adamis Pharmaceuticals’ failed phase 2/3 trial for antiviral Tempol, triggering a 44% drop in its share price.

By James Waldron

 
 
 
 
 

Top Stories

 
 

Bay State biotechs Sesen and Carisma blend together in bid to transform cancer treatment

By Gabrielle Masson

Sesen Bio and privately held Carisma Therapeutics are merging, with plans to combine into a “well-funded” biotech that will operate under the name Carisma and work to advance engineered macrophages for cancer treatment.
 
 
 

Cash-depleted Acerus undergoes strategic review to stay afloat

By Max Bayer

Sexual-health-focused Acerus says it's undergoing a strategic review to find new financial options. The company reported less than $2 million in cash on hand at the end of the second quarter.
 
 
 

Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price

By Nick Paul Taylor

Puma Biotechnology has gone looking for gems in Takeda’s castoffs, emerging from its rummaging with an aurora kinase A inhibitor that failed a phase 3 trial in 2015 but has since moved the needle in another study. The biotech landed a global license for $7 million upfront plus up to $287.3 million in milestones.
 
 
 

Rise of the machines: Novo Nordisk pledges $200M to create first quantum computer for life sciences

By James Waldron

Big pharma has long seen the potential for AI and machine learning to accelerate drug development. But Novo Nordisk is going a step further by channeling $200 million toward the creation of a computer that will outrun anything in existence.
 
 
 

AbCellera doubles down on Vancouver, kicking off 2nd expansion phase to build integrated antibody R&D shop

By Nick Paul Taylor

AbCellera is plowing ahead with its expansion strategy, kicking off the second phase of the development plan for its Vancouver headquarters in a bid to build a fully integrated antibody R&D operation.
 
 
 

Emyria teams with CRO PsychoGenics for MDMA-like drug development

By Joseph Keenan

Biotech Emyria and CRO PsychoGenics have agreed to collaborate on trials of MDMA-inspired drug candidates.
 
 
 
 
 

Resources

 
 

Make the most out of hybrid conferences

Improve your congress competitive intelligence and cut down costs by 50%

Sponsored by: Ferma.AI, a Product of ZoomRx

 
 
 

Leading lab instruments provider saves $2M a year

How a new app brings the power of CRM to a leading lab instruments provider’s field service engineers

Sponsored by: Cognizant

 
 
 

Optimize Digital Engagement Across the Patient Journey

Improve patient engagement, adherence, and outcomes

Sponsored by: Health Catalyst

 
 
 

An Assay Platform to Evaluate Cytokine Release & T Cell Activation

How can we predict the ability of a preclinical drug to inadvertently cause or intentionally inhibit cytokine secretion and T cell activation

Sponsored by: ReachBio | The Cell Biology Experts™

 
 
 

Achieving faster formulation for First In Human supplies

Supporting your product development programme through experience, expertise, and efficiency.

Sponsored by: Almac Pharma Services

 
 
 

Building a Broader Tissue Research Ecosystem

Learn how a centralized platform for pathology images, metadata, and analysis results can connect previously siloed research initiatives and advance our collective understanding of tissue.

Sponsored by: Proscia

 
 
 

Improve Life Sciences Research with AI Workflow Automation

Can an optimized research process--including AI-powered workflow and process automation tools--help get breakthrough drugs to market faster?

Sponsored by: Proscia

 
 
 

The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Sponsored by: Catalent Biologics

 
 
 

Expanding Healthcare Services with Digital Agreement Technology

Read our whitepaper and dive into the way healthcare providers can digitally transform day-to-day work by streamlining costs and increasing agility by removing manual paper burdens.

Sponsored by: DocuSign

 
 
 

Revealing better ways to do business with agile analytics

Learn how a private health insurance company uses analytics to deliver exceptional service to its employees and members

Sponsored by: Genpact

 
 
 

Medical Affairs Metamorphosis, Part III: How Medical Affairs is Becoming a Key Hub for Evidence Generation

This paper explores how Medical Affairs is increasingly playing a key leadership role in evidence planning and generation (part 3 in a series).

Sponsored by: Blue Matter, strategic consultants in the life sciences

 
 
 

Plan for scalable process liquid and buffer preparation

Explore how Thermo Scientific’s Process Liquid Preparation Services can help you plan for scalable buffer preparation.

Sponsored by: Thermo Fisher Scientific

 
 
 

Reduce control arm sizes by up to 22% for HD & ALS RCTs

TwinRCTs require fewer patients and shorten trial timelines for rare neurodegenerative diseases.

Sponsored by: Unlearn

 
 
 

Lead the way to the next breakthrough

ZS helps life sciences companies shape the future of medicine by turning healthcare data into transformative insights. Discover the power of R&D innovation

Sponsored by: ZS

 
 
 
 
 

Events

 
 

European Healthcare Compliance Certificate Program

September ‌19-23, ‌2022

 

Virtual U.S. Healthcare Compliance Certificate Program

October ‌10-13, ‌2022

 

Drug Development Boot Camp® 2022

November ‌16-17, ‌2022